A look at the pharma giant's earnings forecast for the year ahead, with Jean-Pierre Garnier, GlaxoSmithKline CEO and CNBC's Mike Huckman

CNBC's Simon Hobbs spoke to GlaxoSmithKline CEO Jean-Pierre Garnier about how he revolutionized research and development in big pharmaceutic...

...GlaxoSmithKline ...earnings, the company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris Pharmaceuticals Inc. Net income fell to 1.31 billion pounds ($2.61 billion), or 24....

...GlaxoSmithKline ...earnings reported today. A U.S. Food and Drug Administration committee meets on July 30 to review Avandia's safety after researchers said on May 21 that the diabetes pill may ...

...GlaxoSmithKline ...earnings ...ategy under chief executive officer-designate Andrew Witty, who will succeed CEO Jean-Pierre Garnier in May. GlaxoSmithKline is Europe's largest drugmaker. (Source: ...